1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increased late mortality in underweight survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
    Meeting Abstract

    Tonorezos, E. S.; Meacham, L. R.; Chou, J. F.; Moskowitz, C. S.; Leisenring, W. M.; Friedman, D. N.; Sklar, C. A.; Dilley, K. J.; Hudson, M. M.; Mertens, A. C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204
    Meeting Abstract

    Tawbi, H. A. H.; Forsyth, P. A. J.; Algazi, A. P.; Hamid, O.; Hodi, F. S.; Moschos, S. J.; Khushalani, N. I.; Gonzalez, R.; Lao, C. D.; Postow, M. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib (cabo) vs everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Tannir, N. M.; Powles, T.; Escudier, B. J.; Donskov, F.; Grünwald, V.; Sternberg, C. N.; Schmidinger, M.; Schoffski, P.; Szczylik, C.; Peltola, K. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Racial disparities in ovarian cancer survival in New York state
    Meeting Abstract

    Temkin, S. M.; Xu, Z.; Justiniano, C. F.; Becerra, A. Z.; Aquina, C. T.; Boscoe, F. P.; Schymura, M. J.; Fleming, F. J.; Temple, L. K. F.; Minasian, L. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Treatment patterns and characteristics of acute promyelocytic leukemia (APL) patients receiving arsenic trioxide (ATO) therapy in a real-world setting
    Meeting Abstract

    Tang, B.; Gabriel, S.; Zhou, J.; Pathak, A. K.; Irwin, D.; Riehle, E.; Lo-Coco, F.; Tallman, M. S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • ATOMIC-Meso: A randomized phase 2/3 trial of ADI-PEG2O or placebo with pemetrexed and cisplatin in patients with argininosuccinate synthetase 1-deficient non-epithelioid mesothelioma
    Meeting Abstract

    Wojciech Szlosarek, P.; Baas, P.; Ceresoli, G. L.; Fennell, D. A.; Gilligan, D.; Johnston, A.; Lee, P.; Mansfield, A. S.; Nolan, L.; Nowak, A. K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase Ia and lb studies of the novel carcinoembryonic antigen (CEA) 1-cell bispecific (CEA CD3 TCB) antibody as a single agent and in combination with atezolizumab: Preliminary efficacy and safety in patients with metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Tabernero, J.; Melero, I.; Ros, W.; Argiles, G.; Marabelle, A.; Rodriguez-Ruiz, M. E.; Albanell, J.; Calvo, E.; Moreno, V.; Cleary, J. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical utility of clonality testing by next generation sequencing in the monitoring of B-cell and T-cell malignancies
    Meeting Abstract

    Syed, M. H.; Ho, C.; Petrova-Drus, K.; Yao, J.; Yu, W.; Zehir, A.; Nafa, K.; Arcila, M. E.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Will Chinese oncologists refer cancer survivors to psychological support for survivorship care? A cross-sectional survey
    Meeting Abstract

    Sun, L.; Yang, Y.; Wang, X.; Chen, D.; Mao, J. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia (R/R AML): Results of a phase I dose-escalation and expansion study
    Meeting Abstract

    Stein, E. M.; Dinardo, C. D.; Pollyea, D. A.; Fathi, A. T.; Roboz, G. J.; Altman, J. K.; Stone, R. M.; Flinn, I.; Kantarjian, H. M.; Collins, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save